USPTO serial 79236576
CYPRIO
Reviewed by CopyMark Law Group
Reg. 5802868Status 709
- Filing date
- Status date
- Registration date
- Jul 16, 2019
- Examiner
- KAPLAN, VALERIE ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CYPRIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Isabelle Greenberg
Isabelle Greenberg CRGO Law7777 Glades Road Suite 100Boca Raton, FL 33434UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry, science and for research, namely, solvents, surfactants, buffers and minerals; bacterial, bacteriological, biological, chemical and biochemical preparations for use in industry, science and for research; preparations of micro-organisms, cells, stem cells and bacteria for use in industry, science and for research; chemical products for analyses in laboratories; diagnostic preparations for use in industry, science and for research; chemical, biochemical and biological reagents for use in industry, science and for research; in vitro diagnostic reagents and agents for use in industry, science and for research; cultures of biological tissues and micro-organisms for use in industry, science and for research; micro-biological culture media for use in industry, science and for research; stem cells for use in industry, science and for research; cell culture media for use in industry, science and for research; biological preparations for cell cultures for use in industry, science and for research; biological tissues and matrices of tissues, namely, human and animal tissues and blood, and organs for scientific and pharmaceutical research; chemical products for the development of biotechnological products for use in industry, science and for research; testing, sampling and diagnostic kits for use in industry, science and for research comprised of reagents, chemical, biochemical and biological agents and products; chemical test kits comprising reagents, chemical, biochemical and biological agents and products for testing for use in industry, science and for research; chemical, biochemical and biological preparations, and chemical reagents and test kits therefor for research and development relating to pharmaceutical products and medicines, biological tissue repair, replacement of organs or developments of artificial organs; test kits for measuring gene expression, secretion and protein activity for use in industry, science and for research comprised of reagents, chemical, biochemical and biological agents and products; chemical products for encapsulation or coating of active chemical ingredients for use in industry, science and for research; chemical products for cell encapsulation for use in industry, science and for research; chemical products for three-dimensional cell culture for use in industry, science and for research; encapsulated biological products with cell culture for pharmaceutical, scientific use, for diagnosis and for research; encapsulated or co-encapsulated cells, stem cells and microorganisms secreting biological products for pharmaceutical, scientific use, for diagnosis and for research | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals, medical and veterinary preparations for the treatment of liver, pancreas, bladder, kidney, stomach, intestine, spleen, prostate, heart, brain, nerve, cartilage, ligament, joint, tendon, skin, vein, bone, muscle, eye, ear, tongue, lung and bronchi diseases; food supplements for humans and animals; materials, namely, plasters for dressings for medical use; synthetic material for dental fillings and dental impressions; disinfectants; products for destroying vermin, namely, vermin destroying preparations; fungicides, herbicides; bacterial, bacteriological, biological and chemical preparations for medical and veterinary use, namely, bacterial, bacteriological, biological or chemical buffers for maintaining micro-tissues in physiological conditions; preparations of micro-organisms, cells, stem cells and bacteria for medical or veterinary use; diagnostic preparations for medical and veterinary use; chemical, biochemical or biological reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; in vitro diagnostic reagents and agents for medical and veterinary use; cultures of biological tissues and microorganisms for medical and veterinary use; micro-biological culture media for medical and veterinary use; cells and stem cells for medical and veterinary use; cell culture media for medical and veterinary use; biological preparations for cell cultures for medical and veterinary use, namely, biological preparations for the treatment of liver, pancreas, bladder, kidney, stomach, intestine, spleen, prostate, heart, brain, nerve, cartilage, ligament, joint, tendon, skin, vein, bone, muscle, eye, ear, tongue, lung and bronchi diseases; tissues and matrices of tissues and organs for medical and veterinary use; chemical products for the development of pharmaceutical and biotechnological products for medical and veterinary use, namely, biological products, deoxyribonucleic acid, ribonucleic acid, small interfering ribonucleic acid, proteins and chemical compounds with therapeutic effects; surgical implants composed of living tissue; grafts living tissues; living tissues, micro-tissues and organs for medical and veterinary use, namely, implants comprising living tissue; preparations for 3D bio-printing of living tissues, micro-tissues and organs for medical and veterinary use, namely, bio-inks comprised of human or animal living cells, tissues and micro-tissues; pharmaceutical products for tissue regeneration, tissue repair or tissue processing for medical or veterinary use; testing, sampling and diagnostic kits for medical and veterinary use for testing of body fluids for use in disease detection, namely, liver, pancreatic, intestinal, neuronal, cardiac, ocular, muscular and cartilage diseases; testing kits comprising reagents, chemical, biochemical, biological or pharmaceutical agents and products for testing for medical and veterinary use, namely, for analyzing stem cells for use in tissue, microtissue and organ transplants; chemical, biochemical and biological preparations, and chemical reagents and test kits therefor for medical or veterinary use for the development of pharmaceutical products and medicines, for biological tissue repair, replacement of organs and development of artificial organs; test kits for measuring gene expression, secretion and protein activity for medical and veterinary use comprised of chemical, biochemical and biological reagents; Chemical products for use in encapsulation and coating of active ingredients and pharmaceutical substances for medical and veterinary use; chemical products for cell encapsulation for medical and veterinary use; chemical products for three dimensional cell culture for medical and veterinary use; cartridges containing tissues, micro-tissues or organs for transplantation for medical and veterinary use; cartridges containing tissues, micro-tissues and organs for integration into bio-artificial extra-corporal organ machines and apparatus for medical and veterinary use; biological products encapsulated with cell cultures for medical, veterinary and pharmaceutical use, namely, proteins, nucleic acid, fatty acid, toxins, viruses, bacteria, parasites and fungi; encapsulated and co-encapsulated cells, stem cells and micro-organisms secreting biological products for medical, pharmaceutical and veterinary use, namely, human and animal cells, stem cells, proteins, nucleic acid, fatty acid, toxins, viruses, bacteria, parasites and fungi | SECTION 71 - CANCELLED | — |
| 007 | Machines and machine tools, namely, machines for manufacturing capsules for cells, stem cells and micro-organisms, cell encapsulation machines, 3D culture machines; motors and engines other than for land vehicles; machines for encapsulation; machines for encapsulation and coating of chemical active ingredients, pharmaceutical substances and active ingredients; machines for cell encapsulation; machines for cell encapsulation for the production of tissues, micro-tissues and organs; machines for cell culture; machines for three-dimensional cell culture; 3D printing machines; machines for 3D bio-printing; machines for printing and 3D bio- printing of tissues, micro-tissues and organs; cartridges containing materials and bio-materials of 3D printing and 3D bio-printing in the nature of human and animal cell, microtissue and extracellular matrix cartridges | SECTION 71 - CANCELLED | — |
| 009 | Scientific, optical, weighing, measuring, signaling, checking and teaching apparatus and instruments, namely, optical detectors for selecting and sorting cells and microtissues; apparatus for recording, transmission or reproduction of sound or images; software for controlling and operating scientific and laboratory apparatus and instruments for cell encapsulation, for cell encapsulation for the production of tissues, microtissues and organs, for producing 3D tissues, microtissues and organs and for 3D cell culture; downloadable computer software applications for controlling and operating scientific and laboratory apparatus and instruments for cell encapsulation, for cell encapsulation for the production of tissues, microtissues and organs, for producing 3D tissues, microtissues and organs and for 3D cell culture; interfaces for computers; laboratory robots; furniture especially made for laboratories; DNA chips; probes for scientific use; safety cabinets for scientific use, namely, biological safety cabinets; scientific and laboratory apparatus and instruments for cell encapsulation, namely, injectors for simultaneous fluid injections for the manufacture of cell capsules; scientific and laboratory apparatus and instruments for cell encapsulation for production of tissues, micro-tissues and organs, namely, injectors for simultaneous fluid injections for the manufacture of capsules containing human or animal cells; scientific and laboratory apparatus and instruments for the production of 3D tissues, micro-tissues and organs, namely, injectors for simultaneous fluid injections for the manufacture of capsules containing human or animal cells producing tissues, microtissues and organs in 3D; biochips for research and scientific purposes; scientific and laboratory equipment and instruments for three-dimensional cell culture, namely, injectors for simultaneous fluid injections for the manufacture of capsules containing human or animal cells used for three-dimensional cell culture | SECTION 71 - CANCELLED | — |
| 010 | Medical and veterinary apparatus and instruments, namely, dialysis machines and extracorporeal bio-artificial organ apparatus and instruments; artificial limbs, eyes and teeth; orthopedic articles in the nature of orthopedic footwear and orthopedic braces; suture material; diagnostic and analysis apparatus for medical use, namely, blood indicator measurement and analysis apparatus; special furniture for medical use; artificial skin for surgical use; joint prostheses; receptacles for applying medicines sold empty, namely, medical fluid injectors; ultrasound probes for medical use; apparatus and instruments for testing relating to the repair of biological tissues, replacement of organs or development of artificial organs; artificial implants; artificial organs, namely, implants consisting of artificial materials; artificial tissues and micro-tissues in the nature of implants consisting of artificial materials; synthetic bio materials for repair of biological tissues, replacement of organs or development of artificial organs; apparatus and instruments for medical use for the encapsulation or coating of chemical active ingredients, pharmaceutical substances and active ingredients; apparatus and instruments for medical use for cell encapsulation; apparatus and instruments for medical use for cell encapsulation for the production of tissues, micro-tissues and organs; apparatus and instruments for medical use for cell culture; apparatus and instruments for medical use for 3D cell culture; patient assistance machines and apparatus for blood purification and detoxification for medical use; bio-artificial extra-corporal organ machines and apparatus for medical use, namely, bio-artificial extra-corporal organ machines and apparatus for the treatment and support of patients pending organ transplants | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services as well as research and design services relating thereto in the field of scientific and technological research project management; scientific laboratory services for analysis, research and development in the technical, scientific and industrial fields; design and development of computer hardware and software; engineering; conducting clinical trials for others; scientific laboratory services for analysis, research and development relating to bacteriology, chemistry, biochemistry, cosmetology, diagnosis, medical diagnosis, physics, biology, biotechnology, genetics, microbiology and bio materials; research and development in the medical and pharmaceutical fields; research and development in the field of cell encapsulation; research and development in the field of 3D printing and 3D bio-printing; research and development in the field of cell culture and 3D cell culture; research and development in the field of the production of tissues, micro-tissues and organs; research and development of new products for others; research and development of testing, sampling and diagnostic kits, reagents, chemical, biochemical, biological and pharmaceutical products for research and for industrial, scientific, medical and pharmaceutical use; research and development of chemical, biochemical, biological, pharmaceutical products and medicines and testing kits therefor for repair of biological tissues, replacement of organs or development of artificial organs; scientific development of methods for testing and testing kits; biotechnology services, namely, development and conduct of biological and biotechnological tests, namely, gene-targeted ribonucleic acid sequencing and molecular and deoxyribonucleic acid barcoding; scientific and medical research and development in the field of culture, development and production of cells, tissues, micro-tissues and organs; DNA analysis services for scientific research purposes in the nature of analysis, testing and reading of gene expressions, protein activity, toxicity, viability from fluids, cells, stem cells, micro-organisms, tissues, micro- tissues and organs for research and for industrial, scientific, medical and pharmaceutical use | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cyprio
- Other trademarks owned by Cyprio
- Other trademarks owned by Cyprio
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named CYPRIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 30, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 16, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 22, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 1, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 1, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 1, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 16, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 17, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 22, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 16, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 16, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 19, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |